|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$69,351
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$225,712
|
$90,285
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
$2,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
$223,491
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
1U54CA190152-01
|
$697,934
|
$376,884
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-08S1
|
$6,300,000
|
$1,575,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-08
|
$1,900,000
|
$475,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,360,387
|
$68,019
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
1U54CA190146-01
|
$700,000
|
$343,000
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$557,103
|
$27,855
|
Steinberg, Seth
|
CCR (NCI)
|
|
Cancer Center Core Support Grant
|
3P30CA016086-38S1
|
$75,000
|
$3,750
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-38S3
|
$11,838
|
$592
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-38S4
|
$149,896
|
$7,495
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-38
|
$6,597,984
|
$329,899
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
2P30CA016042-39
|
$4,295,192
|
$558,375
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
3P30CA016042-39S1
|
$75,000
|
$9,750
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
3P30CA016042-39S2
|
$308,000
|
$40,040
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant-P30
|
3P30CA093373-12S1
|
$109,731
|
$3,292
|
DE VERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant-P30
|
3P30CA093373-12S2
|
$75,000
|
$2,250
|
DE VERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant-P30
|
3P30CA093373-12S3
|
$199,785
|
$5,994
|
DE VERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Center Support Grant-P30
|
5P30CA093373-12
|
$3,044,422
|
$91,333
|
DE VERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Cancer Research International Training and Intervention Consortium (CRITIC)
|
1U54CA190155-01
|
$687,250
|
$213,048
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150 - 10362
|
$414,657
|
$41,466
|
Engels, Eric
|
DCEG (NCI)
|
|
CCR VB FACS CORE
|
ZIC BC 010936
|
$221,097
|
$44,219
|
McKinnon, Katherine
|
CCR (NCI)
|
|
Characterization of ER-localized Activity of HHV-8 Interleukin-6
|
5F31CA171933-03
|
$42,676
|
$42,676
|
COUSINS, EMILY
|
JOHNS HOPKINS UNIVERSITY
|
|
Chromatin structure maintenance and cancer
|
5R01CA148768-05
|
$312,379
|
$156,190
|
YOU, JIANXIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$780,353
|
$234,106
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-45
|
$2,516,380
|
$125,819
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-45S1
|
$92,630
|
$4,632
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$257,878
|
$128,939
|
Burke, Terrence
|
CCR (NCI)
|
|
Development of a Small Molecule Inhibitor for KSHV LANA
|
1R01CA186775-01
|
$383,875
|
$383,875
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Development of a Vaccine for HIV/AIDS: Cellular Immunity
|
ZIA BC 011062
|
$531,436
|
$175,374
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Humoral Immunity
|
ZIA BC 011058
|
$1,860,026
|
$558,008
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Translation to the Clinic
|
ZIA BC 011063
|
$265,718
|
$87,687
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$70,941
|
$21,282
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Disruption of Cellular Messenger RNA Processing Events by the Kaposi's Sarcoma-As
|
5R01CA136367-05
|
$289,524
|
$144,762
|
GLAUNSINGER, BRITT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
DNA Vaccines
|
ZIA BC 010749
|
$1,095,202
|
$547,601
|
Pavlakis, George
|
CCR (NCI)
|
|
Early Events in KSVH Infection of Primary B-cells
|
5P01CA174439-02
|
$1,771,294
|
$885,647
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Early events of in vitro KSHV infection
|
5R01CA168472-03
|
$310,970
|
$310,970
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$799,639
|
$159,928
|
Carrington, Mary
|
CCR (NCI)
|
|
Escape from gammaherpesvirus-induced mRNA destruction
|
5R01CA160556-04
|
$300,791
|
$300,791
|
GLAUNSINGER, BRITT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$73,835
|
N/A
|
National Institutes of Health
|
|
Functions of KSHV microRNAs
|
ZIA BC 011176
|
$636,276
|
$318,138
|
Ziegelbauer, Joseph
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$832,381
|
$166,476
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$333,231
|
$3,332
|
Gottesman, Michael
|
CCR (NCI)
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-15
|
$374,795
|
$374,795
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genome Persistence of KSHV
|
5R01CA171979-02
|
$289,837
|
$289,837
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Herpesviral, Oncogenesis, Latency and Reactivation
|
5P01CA019014-35
|
$1,777,079
|
$924,081
|
RAAB-TRAUB, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
HIV AIDS cancer match U.S.
|
ZIA CP010150 - 10071
|
$58,619
|
$17,586
|
Engels, Eric
|
DCEG (NCI)
|
|
HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development
|
ZIA BC 010524
|
$213,009
|
$106,505
|
Nicklaus, Marc
|
CCR (NCI)
|
Total relevant funding to Kaposi Sarcoma for this search: $24,386,483
|